NCT07547098Recruiting
Study on Construction of Whole Lifecycle Cohort, Big Data Management and Clinical Prognosis of Cardio-Renal-Metabolic (CKM) Syndrome
Source: ClinicalTrials.gov · Last updated 23 Apr 2026
Brief summary (registry, in English)
This is a single-center observational registry study aiming to establish a structured clinical and multimodal imaging database for cardiovascular-kidney-metabolic (CKM) populations and to support lifecycle follow-up and outcome management. Adult patients aged 18-80 years with cardiovascular, kidney, and/or metabolic diseases or key data for CKM phenotyping will be enrolled at the First Affiliated Hospital of Fujian Medical University. The study integrates retrospective data entry and prospective follow-up, including clinical records, laboratory tests, medications, electrocardiography, echocardiography, vascular function assessment, carotid and abdominal ultrasound, bone density, coronary CTA and post-processing data. The primary outcome is the first occurrence of a cardiorenal composite endpoint. Participants will be followed for up to 5 years through active annual follow-up and passive monthly data updates to support risk stratification, real-world evidence generation, and CKM management pathway optimization.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 8000 (estimated)
- First submitted
- 13 Apr 2026
- Start date
- Mar 2026
- Primary completion date
- Feb 2031
- Lead sponsor
- First Affiliated Hospital of Fujian Medical University
- Diseases
- Chronic kidney disease
- NCT number
- NCT07547098
What you commit to
- Study type: Observational
- Planned participants: 8000
- From Mar 2026 to the primary completion date, Feb 2031
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe psychiatric disease or cognitive impairment precluding participation.
- End-stage disease with expected survival less than 1 year.
Other
- Refusal to provide written informed consent.
- Long-term absence more than 6 months preventing reliable follow-up.
- Participation in another clinical study that may interfere with endpoint adjudication.
- Missing key fields preventing linkage of examinations, imaging, and outcomes.
Who the study is looking for
- Age 18 years or older.
- Inpatient record available at the First Affiliated Hospital of Fujian Medical University with retrievable identifiers for data linkage.
- Cardiovascular disease, kidney disease, metabolic disease, or key examination/laboratory information supporting CKM phenotyping.
- Willingness to participate and provision of written informed consent.
- Ability to complete baseline assessment and follow-up.
- Full civil capacity and ability to understand study information.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The First Affiliated Hospital of Fujian Medical University Coordinator of this site? Confirm its status | Fuzhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.